RWMG
TRIB

Redwood Wealth Management Group’s Trinity Biotech TRIB Stock Holding History

Redwood Wealth Management Group’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,030
Closed -$4.32K – 1010
2024
Q2 		$4.32K Buy
+2,030
New +$3.94K ﹤0.01% 767
2024
Q1 		– Sell
-2,830
Closed -$6.07K – 141
2023
Q4 		$6.07K Sell
2,830
-500
-15% -$1.19K 0.01% 141
2023
Q3 		$12.2K Sell
3,330
-60
-2% -$246 0.01% 142
2023
Q2 		$16.1K Hold
3,390
– – 0.02% 147
2023
Q1 		$15.9K Hold
3,390
– – 0.02% 154
2022
Q4 		$16.8K Buy
+3,390
New +$20.5K 0.02% 142

Other funds holding TRIB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return

Redwood Wealth Management Group's TRIB Position: Q3 2024 in Review

Redwood Wealth Management Group sold out of Trinity Biotech (TRIB) in Q3 2024, closing a stake of 2,030 shares — an estimated $4.32K sold.

Redwood Wealth Management Group first reported a position in TRIB in Q4 2022 and held it in 6 quarters. The position peaked at $16.8K in Q4 2022. 19 funds tracked by Wall St. Rank hold TRIB as of Q3 2024.

  • Redwood Wealth Management Group reported no remaining Trinity Biotech position as of Q3 2024 after selling out during the quarter.
  • Redwood Wealth Management Group sold 2,030 Trinity Biotech shares in Q3 2024, an estimated $4.32K.
  • Redwood Wealth Management Group first reported a position in Trinity Biotech in Q4 2022 and held it in 6 quarters.
  • Redwood Wealth Management Group's Trinity Biotech position peaked at $16.8K in Q4 2022.
  • 19 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2024.

Based on Redwood Wealth Management Group's 13F filing for Q3 2024, filed 13 Nov 2024.